IL36G and neoplasm: To further validate antitumor effects of IL-36γ in a therapeutic context, we intratumorally administered either adeno-associated virus–expressing (AAV-expressing) IL-36γ or recombinant mouse (rm) IL-36γ protein and observed significant reduction in tumor growth (Supplemental Figure 1D and Figure 1C).